Literature DB >> 35000090

Minimally Invasive Secondary Cytoreductive Surgery for Superficial Celiac and Cardio-Phrenic Isolated Nodal Recurrence of Ovarian Cancer.

M Loverro1, R Ergasti1, C Conte1,2, V Gallitelli1, D Nachira3, G Scaglione1,4, A Fagotti1,2, G Scambia1,2, V Gallotta5.   

Abstract

Entities:  

Mesh：

Year:  2022        PMID： 35000090     DOI： 10.1245/s10434-021-11267-5

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  8 in total

1.  Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations.

Authors:  Valerio Gallotta; Gabriella Ferrandina; Giuseppe Vizzielli; Carmine Conte; Alessandro Lucidi; Barbara Costantini; Agostino Maria De Rose; Andrea Di Giorgio; Gian Franco Zannoni; Anna Fagotti; Giovanni Scambia; Vito Chiantera
Journal:  Ann Surg Oncol       Date:  2017-07-17       Impact factor: 5.344

2.  Minimal access surgery compared to laparotomy for secondary surgical cytoreduction in patients with recurrent ovarian carcinoma: Perioperative and oncologic outcomes.

Authors:  Ane Gerda Z Eriksson; Ashley Graul; Miao C Yu; Anthony Halko; Dennis S Chi; Oliver Zivanovic; Ginger J Gardner; Yukio Sonoda; Richard R Barakat; Nadeem R Abu-Rustum; Mario M Leitao
Journal:  Gynecol Oncol       Date:  2017-05-17       Impact factor: 5.482

3.  Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience.

Authors:  Valerio Gallotta; Anna Fagotti; Francesco Fanfani; Gabriella Ferrandina; Camilla Nero; Barbara Costantini; Salvatore Gueli Alletti; Vito Chiantera; Alfredo Ercoli; Giovanni Scambia
Journal:  Surg Endosc       Date:  2014-01-11       Impact factor: 4.584

4.  Pattern and impact of metastatic cardiophrenic lymph nodes in advanced epithelial ovarian cancer.

Authors:  Sonia Prader; Nils Vollmar; Andreas du Bois; Florian Heitz; Stephanie Schneider; Beyhan Ataseven; Mareike Bommert; Kai-Uwe Waltering; Sebastian Heikaus; Jens Albrecht Koch; Pier Francesco Alesina; Alexander Traut; Philipp Harter
Journal:  Gynecol Oncol       Date:  2018-11-18       Impact factor: 5.482

5.  Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.

Authors:  M Petrillo; A Fagotti; G Ferrandina; F Fanfani; B Costantini; G Vizzielli; L Pedone Anchora; C Nero; P A Margariti; G Scambia
Journal:  Gynecol Oncol       Date:  2013-06-20       Impact factor: 5.482

6.  Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.

Authors:  A Martinez; C Pomel; E Mery; D Querleu; L Gladieff; G Ferron
Journal:  Gynecol Oncol       Date:  2011-02-03       Impact factor: 5.482

7.  Pathological diagnosis and cytoreduction of cardiophrenic lymph node and pleural metastasis in ovarian cancer patients using video-assisted thoracic surgery.

Authors:  Myong Cheol Lim; Hyun-Sung Lee; Dae Chul Jung; Ji Young Choi; Sang-Soo Seo; Sang-Yoon Park
Journal:  Ann Surg Oncol       Date:  2009-04-30       Impact factor: 5.344

8.  Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.

Authors:  V Gallotta; M Bruno; C Conte; M T Giudice; F Davià; F Moro; G F Zannoni; A Fagotti; M De Bonis; E Capoluongo; G Scambia; G Ferrandina
Journal:  Eur J Surg Oncol       Date:  2020-02-06       Impact factor: 4.424
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.